Latest Insider Transactions at China Pharma Holdings, Inc. (CPHI)
This section provides a real-time view of insider transactions for China Pharma Holdings, Inc. (CPHI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CHINA PHARMA HOLDINGS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CHINA PHARMA HOLDINGS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Zhilin Li CEO & Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
13,757,063
+47.61%
|
$0
$0.14 P/Share
|
|
Sep 09
2021
|
Zhilin Li CEO & Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,760,000
+11.3%
|
$0
$0.67 P/Share
|
|
Dec 23
2020
|
Zhilin Li CEO & Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,000,000
+14.23%
|
-
|